Several telehealth programs publish a month-to-month recurring rate for compounded semaglutide or tirzepatide injection below MEDVi's displayed refill rate. This post compares them on equal terms, shows what is due upfront and what the recurring payment includes, and explains when a lower headline price is not the lower cost.

A shortlist of MEDVi alternatives whose pricing and terms could be read from official pages on September 22, 2026, compared on recurring cost, medication and route, membership fees, support, and cancellation rules, with unknowns labeled rather than guessed and a plain statement of where PlexusDx fits.

Advertised first-month rates say little about what a GLP-1 program costs over six or twelve billing cycles. This guide compares MEDVi with alternatives whose recurring price can be verified on their own pages, matches duration to duration, and lists the commitment and refund terms that change the long-term picture.